Joseph DeVivo appointed President, CEO, and Chairman of Butterfly Network, effective April 24, 2023

Butterfly Network, Inc.

DeVivo replaces Jonathan Rothberg as CEO; Rothberg remains on board.
Compensation: $875k base salary, 125% target bonus, $500k sign-on bonus (recoverable within 12 months).
Equity grants: 2.4M time-based RSUs (vesting over 3 yrs), 1.6M performance RSUs tied to stock price targets of $3, $4.50, $6.
DeVivo previously President at Teladoc Health, CEO of InTouch Health (sold to Teladoc for $1.1B), and Executive Chairman of Caption Health (sold to GE Healthcare).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph DeVivo

President and Chief Executive Officer, principal executive officer, and Chairman of the Board

BFLY · Butterfly Network, Inc.

Effective: 2023-04-24
Filed: April 24, 2023, 7:59 PM ET

the Board approved the appointment of Joseph DeVivo as President and Chief Executive Officer, principal executive officer, and Chairman of the Board, effective as of April 24, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph DeVivo was appointed as President and Chief Executive Officer, principal executive officer, and Chairman of the Board at Butterfly Network, Inc..

Action: appointed
Role: President and Chief Executive Officer, principal executive officer, and Chairman of the Board

Exact text from the filing

the Board approved the appointment of Joseph DeVivo as President and Chief Executive Officer, principal executive officer, and Chairman of the Board, effective as of April 24, 2023

View on SEC.gov

Butterfly Network, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-006473

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.